Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

ClinicalTrials.gov ID: NCT01128959

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01128959. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and tolerability of intravenous (IV) carbamazepine (CBZ) administered as multiple 15 minute infusions and a single 5 minute infusion to adult patients with epilepsy on stable higher doses of oral CBZ.

Study identification

NCT ID
NCT01128959
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lundbeck LLC
Industry
Enrollment
108 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2010 (Type not available)
Primary completion
Jan 2013 (Actual)
Completion
Jan 2013 (Actual)
Last update posted
Jan 16, 2018

2010 – 2013

United States locations

U.S. sites
29
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Mayo Clinic Arizona Phoenix Arizona 85054 —
Clinical Trials Incorporated Little Rock Arkansas 72205 —
Collaborative Neuroscience Network, Inc. Torrance California 90502 —
Denver Health and Hospital Authority Denver Colorado 80204 —
University of South Florida Tampa Florida 33606 —
University of Illinois at Chicago Chicago Illinois 60612 —
Southern illinois University School of Medicine Springfield Illinois 62702 —
Central DuPage Hospital Winfield Illinois 60190 —
Via Christi Epilepsy Center Wichita Kansas 67214 —
Leonard J. Chabert Medical Center Houma Louisiana 70363 —
Louisiana Research Associates New Orleans Louisiana 70114 —
Ochsner Clinic Foundation New Orleans Louisiana 70115 —
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20815 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Minnesota & Prism Research Saint Paul Minnesota 55114 —
The Comprehensive Epilepsy Care Center for Children and Adults Chesterfield Missouri 63017 —
Langone Medical Center NYU Comprehensive Epilepsy Center New York New York 10016 —
Columbia University Medical Center: Dept of Neurology New York New York 10032 —
University of Rochester Rochester New York 14642 —
SUNY Upstate Medical University Syracuse New York 13210 —
Montefiore Medicical Center The Bronx New York 10467 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Cleveland Clinic Cleveland Ohio 44195 —
Temple University Health systems Philadelphia Pennsylvania 19140 —
Medical University of South Carolina Charleston South Carolina 29425 —
Neurological Clinic of Texas, P.A. Dallas Texas 75230 —
Scott & White Memorial Hospital Temple Texas 76508 —
University of Virginia Charlottesville Virginia 22903 —
VCU Medical Center Richmond Virginia 23298-0599 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01128959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2018 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.